The relentless pursuit of novel therapeutics in the pharmaceutical industry relies heavily on the availability of versatile and high-quality chemical intermediates. Methyl 3-Iodo-4-Methylbenzoate (CAS 90347-66-3) has emerged as a pivotal compound, playing a crucial role in the synthesis of a wide array of pharmacologically active molecules. For R&D scientists and procurement specialists, understanding the applications and sourcing of this aromatic ester is key to advancing drug discovery and development.

Methyl 3-Iodo-4-Methylbenzoate is an aromatic compound that features an iodine atom, a methyl group, and a methyl ester group. This specific arrangement of functional groups imparts unique reactivity, making it an ideal starting material or intermediate in complex synthetic pathways. Its high purity, typically above 98% as a white to off-white crystalline solid, is a testament to the precision manufacturing required for pharmaceutical applications.

Key Pharmaceutical Synthesis Applications:

  • API Precursor: The compound serves as a critical building block for synthesizing Active Pharmaceutical Ingredients (APIs). Its structure can be readily modified through various reactions, allowing chemists to introduce specific moieties that are essential for a drug's therapeutic efficacy. For instance, it is used in the development of certain anti-inflammatory agents and compounds targeting specific biological receptors.
  • Cross-Coupling Reactions for Complex Molecules: A significant advantage of Methyl 3-Iodo-4-Methylbenzoate is its participation in palladium-catalyzed cross-coupling reactions like the Suzuki, Heck, and Sonogashira couplings. These reactions are foundational for creating carbon-carbon bonds, enabling the efficient assembly of complex molecular structures found in many modern pharmaceuticals. Researchers often seek to buy this intermediate specifically for these transformations.
  • Drug Discovery and Lead Optimization: In the lead optimization phase of drug discovery, chemists often modify existing molecular scaffolds. Methyl 3-Iodo-4-Methylbenzoate provides a platform for such modifications, allowing for systematic variations in chemical structure to improve potency, selectivity, and pharmacokinetic properties.

Sourcing and Procurement:

For pharmaceutical companies, securing a reliable supply of Methyl 3-Iodo-4-Methylbenzoate is critical. As a trusted manufacturer and supplier in China, we offer this compound with stringent quality controls and competitive price points. Our production facilities are equipped to handle large-scale synthesis, ensuring that we can meet the demands of both R&D projects and commercial manufacturing. When you choose to buy from us, you are opting for consistent quality, reliable delivery, and excellent customer support. We understand the regulatory landscape and the need for transparency, providing necessary documentation and adhering to high production standards.

The versatility and reactivity of Methyl 3-Iodo-4-Methylbenzoate make it an invaluable asset in the pharmaceutical synthesis toolkit. By partnering with a reputable supplier, drug developers can ensure access to this crucial intermediate, accelerating the journey from laboratory synthesis to life-saving medications.